ABSTRACT
The COVID-19 pandemic has caused several millions of deaths and forced the world population to a new normality. This study aims to analyze the air quality variation of several gaseous pollutants (CO, NO2, SO2, O3, PM10, and PM2.5) during the pre-lockdown, lockdown, and unlock period in the city of Monterrey using ground-based measurements. In this research, we proposed to use a control period of previous years to identify parameter variation due to local climate. The results showed a drastic decrease in measured contaminants during the lockdown period as follows: SO2 (−41.9%) > PM10 (−30.5%) > PM2.5 (−25.6%) > NO2 (−14.9%) > CO (−9.8%) compared to the control period (2017–2019). The O3 was the only air pollutant that showed an opposite trend, increasing during lockdown (+15%) and unlock (+2.2%), whereas CO (−16.6%) and NO2 (−30.6%) were further decreased. Moreover, using OMI/AURA satellite data, we detected a NO2 tropospheric column reduction by −1.9% during lockdown concerning the same period in the control interval. Moreover, we found a significant improvement in the Air Quality Index (AQI) due to the lockdown. Our findings indicate an association between air pollutants and economic activity and can be used in future strategies to improve urban air quality. © 2022 by the authors.
ABSTRACT
OBJECTIVE: To determine the prevalence of CMV reactivation in a population admitted for severe COVID-19 to a general hospital. METHODS: Point prevalence study in all hospitalized patients with severe COVID-19 (admitted either to general wards or ICU). Determination of the presence of CMV DNA in circulating blood. COVID-19 was confirmed in patients with compatible clinical manifestations, usually with pneumonia and a positive nasopharyngeal PCR test. RESULTS: We included 140 hospitalized patients with COVID-19 who consented to participate. A total of 16 patients (11.42%), had circulating CMV-DNA in peripheral blood at the time of the study. Patients with positive CMV viral load were mainly ICU patients (11/37 -29,7%) and only 5/103 cases (4,85%) were hospitalized into general wards. The accumulated doses of corticosteroids (prednisone equivalents) in the study day were (median and IQR) 987.50 mg (396.87-2,454.68) and 187.50 mg (75.00-818.12) respectively in CMV positive and negative patients (p < 0.001). A significant proportion of CMV positive patients were discovered because of the study and were clinically unsuspected by their physicians. The coinfected COVID-CMV positive population had a higher risk of accumulated secondary nosocomially-acquired infections and a worse prognosis. CONCLUSIONS: CMV reactivation should be systematically searched in patients in COVID-19 cases admitted to the ICU.